Monoamine oxidases and their inhibitors
Saved in:
Group Author: | ; ; |
---|---|
Published: |
Academic Press,
|
Publisher Address: | London |
Publication Dates: | 2011. |
Literature type: | Book |
Language: | English |
Series: |
International Review of Neurobiology, ; v. 100 |
Subjects: | |
Carrier Form: | xv, 281 p.: ill. ; 24 cm. |
ISBN: |
9780123864673 (hbk.) 0123864674 (hbk.) |
Index Number: | R741 |
CLC: |
R741.05 Q554.4 Q42 |
Call Number: | Q42/M751 |
Contents: |
Includes bibliographical references and index. Structural properties of human monoamine oxidases A and B -- Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence -- Kinetic behavior and reversible inhibition of monoamine oxidases-enzymes that many want dead -- The pharmacology of selegiline -- Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection -- Multimodal drugs and their future for Alzheimer's and Parkinson's disease -- Neuroprotective profile of hte multitarget drug rasagiline in Parkinson's disease -- Rasagiline in Parkinson's disease -- Selective inhibitors of monamine oxidase type B and the "cheese effect" -- A novel anti-Alzheimer's disase drug, ladostigil: neuroprotective, multimodal brain-selective monamine oxidase and cholinesterase inhibitor -- Novel MAO-B inhibitors: protential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease. |